Okay, thank you.
The JODR is separate. There's certainly a suggestion that disorders be separate. Do you think that weakens, in any way, the CDR? Do you think that's simply a compatible partnership? If you had a magic wand--not a big one, a little one--would there be ways in which CDR could make changes?
They've acknowledged there are changes they can make as well, particularly around transparency, which you spoke about as well. The transparency patients have looked for, I know, is not there, other than people are planning on printing or putting out information about why the drug wasn't approved. I don't know what you can put, other than that it wasn't safe, without breaking intellectual property if the drug is not registered.
Could you just speak quickly to the transparency one? Given that CDR is prepared to say they need to do things differently as well, is that possible?
Then I'm done--I know I am; that's why I'm not looking at the chair.